Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

British stocks drop as prospect of no-deal Brexit grows

Published 11/12/2020, 08:19
Updated 11/12/2020, 17:20
© Reuters. A broker reacts on the IG Index the trading floor

By Sagarika Jaisinghani and Shashank Nayar

(Reuters) -London-listed shares ended lower on Friday as investors prepared for Britain to leave the European Union in three weeks without a trade deal, while Rolls-Royce (LON:RR) tumbled after it downgraded this year's forecast.

The blue-chip FTSE 100 shed 0.8%, with energy and banking stocks leading declines. Oil majors BP (LON:BP) and Royal Dutch shell were the biggest drags on the index.

The domestically-focused FTSE 250 slipped 0.7%, bringing weekly declines to nearly 3%, after British Prime Minister Boris Johnson said that it was "very, very likely" that trade talks with the European Union would fail and that the UK would leave the bloc at the end of year without a deal.

The FTSE 250 would slide between 6%-10% and UK bank shares would drop 10%-20% with a no-trade deal Brexit, Morgan Stanley (NYSE:MS) strategists said.

"The increasing likelihood of a no-deal Brexit at the end of the year has definitely dampened mood in the near term, but investors continue to price for a last minute arrangement or further talks even after the year-end deadline," said Andrea Cicione, a strategist at TS Lombard.

German Foreign Minister Heiko Maas said that Britain and EU may have to continue negotiations to complete a deal beyond a deadline set for Sunday and that the talks will not fail as a few more days of discussions are needed.

London's benchmark stock indexes have bounced since a coronavirus-driven crash in March, but have lagged their U.S. and European peers as data suggests a much deeper impact on domestic economic growth.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

A Reuters poll this month found it will take at least two years for UK GDP to reach pre-pandemic levels.

In company news, drugmaker GlaxoSmithKline dropped 0.3% as it said the experimental vaccine it was developing with France's Sanofi (PA:SASY) showed an insufficient immune response in clinical trials.

Rolls-Royce tumbled 7.9% as it deepened this year's cash outflow forecast and warned the outlook remained challenging.

Latest comments

Misleading headline as usual. Brexit doesn’t hang in the balance, Brexit has been acheived, we left the EU last February. A FTA is in the balance simply put because the LPF the EU wants is a trap.
Actually aren't we still in the EU until 31st Dec? The term Brexit covers the divorce agreement. But I agree, the EU are being unreasonable and underhsnd
Well maybe there will some peace in the EU without constant bickering ..
wishful thinking
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.